“The rating reflects our assessment of Halifax’s healthy balance of days’ cash on hand, dominant market position, strong non-operating activity and positive demographic trends within its service area and encouraging economic growth,” said S&P credit analyst Patrick Zagar.
The outlook is stable.
S&P has also affirmed the “A-” long-term rating on Halifax Health’s outstanding series 2006A and series 2015 bonds.
More articles on healthcare finance:
Aurora HealthCare taps Strata Decision for financial analytics
Rhode Island hospital scales back services to stem losses|
Lahey Health’s flagship hospital takes financial hit from Epic transition
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
